Buy, Sell or Hold: Citi keeps a buy on Torrent Pharmaceuticals; Morgan Stanley maintains overweight on Reliance Industries

Brokerages remain positive on select stocks, with Citigroup maintaining a buy rating on Torrent Pharmaceuticals and Morgan Stanley keeping an overweight stance on Reliance Industries. The brokerage, however, has retained a neutral view on Lupin, citing possible moderation in growth beyond FY26 despite strong near-term earnings.